Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Hypoxia inducible factor-1 independent pathways in tumor angiogenesis Mizukami Y; Kohgo Y; Chung DCClin Cancer Res 2007[Oct]; 13 (19): 5670-4Among the factors that can stimulate angiogenesis, vascular endothelial growth factor has emerged as one of the most important, and inhibition of vascular endothelial growth factor has recently shown efficacy in the treatment of advanced colorectal cancer. Hypoxia develops within solid tumors and is one of the most potent stimuli of vascular endothelial growth factor expression. This effect is mediated primarily by hypoxia inducible factor-1 (HIF-1), often considered a master regulator of angiogenesis in hypoxia. Consequently, inhibition of HIF-1 has been proposed as a strategy to block tumor angiogenesis therapeutically. However, accumulating evidence indicates that HIF-independent pathways can also control angiogenesis. This review highlights some of the key signaling pathways independent of HIF-1 that can stimulate angiogenesis in hypoxia. Understanding the full spectrum of molecular pathways that control tumor angiogenesis is critical for the optimal design of targeted therapies.|*Gene Expression Regulation, Neoplastic[MESH]|*Neovascularization, Pathologic[MESH]|Angiogenesis Inhibitors/therapeutic use[MESH]|Antineoplastic Agents/therapeutic use[MESH]|Humans[MESH]|Hypoxia[MESH]|Hypoxia-Inducible Factor 1/metabolism/*physiology[MESH]|Models, Biological[MESH]|Neoplasm Transplantation[MESH]|Neoplasms/*blood supply/metabolism/*pathology[MESH]|Signal Transduction[MESH]|Vascular Endothelial Growth Factor A/antagonists & inhibitors/metabolism[MESH] |